Novavax announces promising early data for its combination COVID-19 and influenza vaccine candidate. The company is also navigating ongoing regulatory reviews for its standalone COVID-19 vaccine.
Novavax is a biotechnology company focused on developing and commercializing innovative vaccines for infectious diseases.
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing